The court said there was nothing on record to show that Bakshi, president of Central Council of Homeopathy (CCH), had influenced any of the homeopathic medical colleges to buy any medicine from Bakson and no personal benefit was being derived by any of the accused while working in CCH in various posts.
"Since, no material has come on record file to show that Bakshi had, at any point of time, utilised any influence to coerce over the homeopathic medical colleges, the court is of the considered view that there was no forced supply of medicines by M/s Bakson Drugs and Pharmaceuticals...
Apart from Bakshi, the court also acquitted Ramjee Singh (vice president of CCH), Arun Bhasme, M R Srivatsan, Kewal Krishan Juneja and B Sohan Singh of the charges of criminal conspiracy under the IPC and under provisions of the Prevention of Corruption Act.
Dr Sibendranath Sinha died during the pendency of the case and proceedings against him were abated by the court.
The court said these doctors were discharging public functions and they were doing honorary service in the field of homeopathy.
The court said the recognition was granted to the colleges as per CCH Act and CBI has failed to prove that the doctors had abused their official position while granting recognition or sanction to various homeopathic colleges and institutions.
CBI had alleged that the doctors had conspired and abused their official position as public servants and irregularly granted recognition to several homeopathic medical colleges.
CBI had alleged that Dr Bakshi asked S P Anand, Secretary
During the trial, the doctors had denied having committed any offence and claimed innocence.
The judge said in the judgement, "Since, CBI has not been able to bring any cogent and reliable evidence to the effect that there was any forced sale of homeopathic medicine on behalf of Bakshi, I am of the considered view that there was no inducement and enticement on behalf of Bakshi to any of the homeopathic medical colleges or institutions to purchase the medicines from M/s Bakson Drugs and Pharmaceuticals Pvt Ltd.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
